Grappling with a backlash against high U.S. prescription drug prices, more pharmaceutical companies are pledging to limit annual increases to under 10 percent – but the tactic is doing little to salve critics, including President-elect Donald Trump, who on Wednesday …
from News – Insurance Journal
没有评论:
发表评论